Mexazolam

CAS : 31868-18-5

Ref. 3D-GBA86818

Informations sur le produit

• Nom: Mexazolam
• Synonymes: 10-Chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one, 10-Chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one, 10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one, Brn 1091849, Cs 386, Melex, Mexazolam [INN:JAN], Mexazolamum, Mexazolamum [INN-Latin], Oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one, 10-chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyl-, Unii-S5969B6237
• CAS: 31868-18-5

Description

Mexazolam is an analog of indirubin, a natural compound that has been shown to have anticancer properties. Mexazolam inhibits kinase activity in human cancer cells, leading to apoptosis and the inhibition of tumor growth. This drug has been shown to be effective against a variety of cancers, including breast, lung, and prostate cancer. Mexazolam works by inhibiting the activity of protein kinases, which are enzymes that play a key role in cell division and proliferation. It is also used as an inhibitor for Chinese hamster ovary (CHO) cell proliferation in urine samples. Its potency as an anticancer agent makes it a promising candidate for further development as a cancer therapy.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 363.2 g/mol
• Formule: C₁₈H₁₆Cl₂N₂O₂
• Degré de pureté: Min. 95%